Catalent Competitors and Similar CompaniesClear all

Catalent's competitors and similar companies include Aldevron, Vetter Pharma, WuXi Biologics, Regeneron Pharmaceuticals, Gilead Sciences, Bristol Myers Squibb and Lonza.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
Aldevron
Aldevron
Aldevron is a contract manufacturer providing biological products for research, clinical and diagnostic applications.
Vetter Pharma
Vetter Pharma
Vetter Pharma-Fertigung is a company that provides services to the pharmaceutical and biotech industries.
WuXi Biologics
WuXi Biologics
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Bristol Myers Squibb
Bristol Myers Squibb
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
Lonza
Lonza
Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.
Founding Date
Founding Date
2007
Founding Date
1998
Founding Date
1950
Founding Date
2010
Founding Date
1988
Founding Date
1987
Founding Date
1887
Founding Date
1897
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Somerset, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Locations
Fargo, US HQ
Madison, US
Locations
Ravensburg, DE HQ
Rankweil, AT
Shanghai, CN
Langenargen, DE
Ravensburg, DE
Ravensburg, DE
Ravensburg, DE
see more
Locations
Wuxi, CN HQ
George Town, KY
Wuppertal, DE
Hong Kong, HK
Dundalk, IE
Cranbury, US
King Of Prussia, US
Locations
Tarrytown, US HQ
Mississauga, CA
München, DE
Bengaluru, IN
Dublin, IE
Limerick, IE
Tokyo, JP
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Princeton, US HQ
Mulgrave, AU
Pinewood, AU
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
see more
Locations
Basel, CH HQ
Baulkham Hills, AU
Antwerpen, BE
Bornem, BE
Verviers, BE
Rio De Janeiro, BR
Dorval, CA
see more
Employees
Employees
17,8006% decrease
Employees
8741% increase
Employees
5,9004% increase
Employees
12,7403% increase
Employees
12,2563% increase
Employees
18,0006% increase
Employees
34,1001% decrease
Employees
18,000
Valuation ($)
Valuation ($)
10.1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
98.6 b
Valuation ($)
82.5 b
Valuation ($)
103.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
19 k
Twitter followers
893
Twitter followers
320
Twitter followers
426
Twitter followers
32.5 k
Twitter followers
73.8 k
Twitter followers
156.9 k
Twitter followers
8.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
116
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
1
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
0.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
48.1
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
15
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
33.62%
Percentage of tweets with engagement (last 30 days)
10%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
$4.3b (FY, 2023)
Revenue (est.)
$300m (Y, 2020)
Revenue (est.)
€892.1m (FY, 2022)
Revenue (est.)
¥17b (FY, 2023)
Revenue (est.)
$13.1b (FY, 2023)
Revenue (est.)
$27.1b (FY, 2023)
Revenue (est.)
$45b (FY, 2023)
Revenue (est.)
CHF6.7b (FY, 2023)
Cost of goods
Cost of goods
$3.2b (FY, 2023)
Cost of goods
N/A
Cost of goods
€178m (FY, 2022)
Cost of goods
¥8.8b (FY, 2023)
Cost of goods
N/A
Cost of goods
$6.5b (FY, 2023)
Cost of goods
$10.7b (FY, 2023)
Cost of goods
CHF4.1b (FY, 2023)
Gross profit
Gross profit
$1b (FY, 2023)
Gross profit
N/A
Gross profit
€714.1m (FY, 2022)
Gross profit
¥8.4b (FY, 2023)
Gross profit
N/A
Gross profit
$20.6b (FY, 2023)
Gross profit
$34.3b (FY, 2023)
Gross profit
CHF2.6b (FY, 2023)
Net income
Net income
($256m) (FY, 2023)
Net income
N/A
Net income
€86.7m (FY, 2022)
Net income
¥3.6b (FY, 2023)
Net income
$4b (FY, 2023)
Net income
$5.6b (FY, 2023)
Net income
$8b (FY, 2023)
Net income
CHF655m (FY, 2023)

Operating

Backlog
Backlog
$2.5b (FY, 2023)
Backlog
N/A
Backlog
N/A
Backlog
$18.5b (H1, 2022)
Backlog
N/A
Backlog
N/A
Backlog
N/A
Backlog
N/A
Countries
Countries
80 (FY, 2023)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
35 (FY, 2021)
Countries
N/A
Countries
28 (FY, 2022)
Customers
Customers
1.2 k (FY, 2023)
Customers
N/A
Customers
125 (FY, 2022)
Customers
N/A
Customers
N/A
Customers
N/A
Customers
N/A
Customers
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
20 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2021)
Phase II Trials Products (Oncology)
15 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
4 (FY, 2021)
Phase III Trials Products (Oncology)
7 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Products
Products
8 k (FY, 2023)
Products
N/A
Products
N/A
Products
N/A
Products
11 (FY, 2022)
Products
21 (FY, 2021)
Products
N/A
Products
N/A

Funding

Total funding raised
Total funding raised
$ 650m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 53.9m
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Aldevron
HQ
Fargo, US

Aldevron is a contract manufacturer providing biological products for research, clinical and diagnostic applications.

View company
Vetter Pharma
HQ
Ravensburg, DE
Employees
5,900↑ 4% increase

Vetter Pharma-Fertigung is a company that provides services to the pharmaceutical and biotech industries.

View company
WuXi Biologics
HQ
Wuxi, CN
Employees
12,740↑ 3% increase

WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
12,256↑ 3% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company